2775. Clinical Outcomes and Treatment-Emergent Resistance of Piperacillin-tazobactam, Cefepime, Carbapenems and Fluoroquinolones for the Treatment of Bloodstream Infections due to AmpC β-Lactamase-Producing Enterobacterales

BACKGROUND: Cefepime (FEP) and carbapenems (CB) are preferred over piperacillin-tazobactam (TZP) for treatment (tx) of Enterobacterales with significant AmpC production due to concerns for inducible resistance. We aimed to determine if dose-optimized TZP is as effective for bloodstream infections (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawanda, Jasanjeet, O’Donnell, Matthew A, Shah, Sunish, Clarke, Lloyd, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679404/
http://dx.doi.org/10.1093/ofid/ofad500.2386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679404/
http://dx.doi.org/10.1093/ofid/ofad500.2386

Ejemplares similares